KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Short-term Investments (2022 - 2023)

ClearPoint Neuro (CLPT) has disclosed Short-term Investments for 2 consecutive years, with $9.9 million as the latest value for Q1 2023.

  • Quarterly Short-term Investments changed N/A to $9.9 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $9.9 million through Mar 2023, changed N/A year-over-year, with the annual reading at $9.9 million for FY2022, N/A changed from the prior year.
  • Short-term Investments hit $9.9 million in Q1 2023 for ClearPoint Neuro, roughly flat from $9.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $21.7 million in Q3 2022 to a low of $9.9 million in Q4 2022.